< Back

'(bone' and 'metastasis)' and '(renal' and 'cell' and 'carcinoma)'
Run an advanced search on this term

Search within:  

Sort results by:      



1-20 of 21   Next >
 
1.  
Renal cell carcinoma. 2011 Jan (revised 2012 May). NGC:009081
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
ACR Appropriateness Criteria® renal cell carcinoma staging. 2015. NGC:010845
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
3.  
ACR Appropriateness Criteria® single brain metastasis. 1999 (revised 2012). NGC:009678
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
4.  
5.  
ACR Appropriateness Criteria® metastatic bone disease. 1995 (revised 2012). NGC:009235
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
6.  
ACR Appropriateness Criteria® spinal bone metastases. 1996 (revised 2012). NGC:009677
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
7.  
ACR Appropriateness Criteria® nasopharyngeal carcinoma. 2015. NGC:010850
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
8.  
ACR Appropriateness Criteria® screening for pulmonary metastases. 1995 (revised 2013). NGC:010164
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
9.  
ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases. 1999 (revised 2014). NGC:010462
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
10.  
ACR Appropriateness Criteria® post-treatment follow-up of renal cell carcinoma. 1996 (revised 2013). NGC:010165
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
11.  
Brain metastases. 2006 Jul (revised 2011). NGC:008770
European Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s)
13.  
Muscle invasive and locally advanced/metastatic bladder cancer. 2011 Jan (revised 2013 Oct). NGC:010249
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
ACR Appropriateness Criteria® pretreatment staging of invasive bladder cancer. 1995 (revised 2012). NGC:009670
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
Management of primary cutaneous squamous cell carcinoma. A national clinical guideline. 2014 Jun. NGC:010740
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Follow-up for clinically localized renal neoplasms: AUA guideline. 2013 Apr. NGC:009917
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
17.  
ACR Appropriateness Criteria® non-invasive clinical staging of bronchogenic carcinoma. 1995 (revised 2013). NGC:010163
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
18.  
ACR Appropriateness Criteria® thyroid carcinoma. 2013. NGC:010177
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
ACR Appropriateness Criteria® staging of testicular malignancy. 1996 (revised 2012). NGC:009247
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
20.  
ACR Appropriateness Criteria® post-treatment surveillance of bladder cancer. 1996 (revised 2014). NGC:010458
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
1-20 of 21   Next >